Generic Product News (September 2016)

Pharmacy Times, September 2016 Men's Health, Volume 82, Issue 9

Read about the new generic products featured in September.

Zydus Pharmaceuticals (USA) Inc

COMPARE TO: Asacol HD (Allergan)

INDICATION: Zydus Pharmaceuticals (USA) Inc has begun shipping Mesalamine Delayed-Release Tablets, an authorized generic of Asacol HD. The product is indicated for the treatment of moderately active ulcerative colitis in adults. Asacol is a registered trademark of Medeva Pharma Suisse AG, licensed to Allergan Pharmaceuticals International Limited.

DOSAGE FORM: Delayed-release tablets: 800 mg

FOR MORE INFORMATION: zydususa.com

AMIODARONE HYDROCHLORIDE TABLETS, 200 MGMARKETED BY: Aurobindo Pharma Ltd

COMPARE TO: Cordarone (Wyeth Pharmaceuticals Inc)

INDICATION: Aurobindo Pharma Ltd has received approval from the FDA for Amiodarone Hydrochloride Tablets, 200 mg, the generic equivalent of Wyeth Pharmaceuticals’ Cordarone. The product is indicated for the treatment of recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia.

DOSAGE FORM: Tablets: 200 mg

FOR MORE INFORMATION: aurobindousa.com

POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USPMARKETED BY: Glenmark Pharmaceuticals

COMPARE TO: K-Dur Extended- Release Tablets USP (Merck, Dohme Corp)

INDICATION: Glenmark Pharmaceuticals recently announced that the FDA has approved Potassium Chloride Extended-Release Tablets USP, the generic equivalent of Merck and Dohme’s K-Dur Extended-Release Tablets, in 750-mg and 1500-mg dosage strengths. The product is indicated to prevent or to treat low blood levels of potassium (hypokalemia).

DOSAGE FORM: Tablets: 750 and 1500 mg

FOR MORE INFORMATION: glenmarkpharma.com

DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULESMARKETED BY: Mylan

COMPARE TO: Dexedrine (Amedra Pharmaceuticals LLC)

INDICATION: Mylan recently launched Dextroamphetamine Sulfate Extended- Release Capsules, the therapeutic equivalent of Amedra Pharmaceuticals’ Dexedrine capsules, in 5-, 10-, and 15-mg dosage strengths. The product is indicated to treat narcolepsy and attention-deficit/hyperactivity disorder for patients 6 to 16 years.

DOSAGE FORM: Capsules: 5, 10, and 15 mg

FOR MORE INFORMATION: mylan.com